newsfilter
← Latest News
ClinicalTrials.gov·

Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension - NCT04857840

The primary efficacy endpoint is the change from baseline in systolic AOBP at Week 12.